147 related articles for article (PubMed ID: 36270892)
1. Challenges, best practices, and lessons learned from oral cholera mass vaccination campaign in urban Cameroon during the COVID-19 era.
Amani A; Ngo Bama S; Dia M; Nguefack Lekelem S; Linjouom A; Mossi Makembe H; Ateke Njoh A; Cheuyem Lekeumo FZ; Eyebe S; Nguefack-Tsague G; Kamgno J
Vaccine; 2022 Nov; 40(47):6873-6879. PubMed ID: 36270892
[TBL] [Abstract][Full Text] [Related]
2. Reactive mass vaccination campaign against cholera in the COVID-19 context in Cameroon: challenges, best practices and lessons learned.
Amani A; Fouda AAB; Nangmo AJ; Bama SN; Tatang CA; Mbang MA; Douba ECE; Noula AGM; Dia M; Bouhenia M
Pan Afr Med J; 2021; 38():392. PubMed ID: 34381536
[TBL] [Abstract][Full Text] [Related]
3. A reactive vaccination campaign with single dose oral cholera vaccine (OCV) during a cholera outbreak in Cameroon.
Amani A; Tatang CA; Bayiha CN; Woung M; Ngo Bama S; Nangmo A; Mbang MA; Epee Douba E
Vaccine; 2021 Feb; 39(8):1290-1296. PubMed ID: 33494966
[TBL] [Abstract][Full Text] [Related]
4. An innovative approach in monitoring oral cholera vaccination campaign: integration of a between-round survey.
Ateudjieu J; Yakum MN; Goura AP; Tembei Ayok M; Guenou E; Kangmo Sielinou CB; Kiadjieu FF; Tsafack M; Douanla Koutio IM; Tchio-Nighie KH; Tchokomeni H; Ntsekendio PN; Sack DA
BMC Public Health; 2022 Feb; 22(1):238. PubMed ID: 35123444
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and acceptability of oral cholera vaccine mass vaccination campaign in response to an outbreak and floods in Malawi.
Msyamboza KP; M'bang'ombe M; Hausi H; Chijuwa A; Nkukumila V; Kubwalo HW; Desai S; Pezzoli L; Legros D
Pan Afr Med J; 2016; 23():203. PubMed ID: 27347292
[TBL] [Abstract][Full Text] [Related]
6. Cholera and COVID-19 pandemic prevention in multiple hotspot districts of Uganda: vaccine coverage, adverse events following immunization and WASH conditions survey.
Bwire G; Kisakye A; Amulen E; Bwanika JB; Badebye J; Aanyu C; Nakirya BD; Okello A; Okello SA; Bukenya JN; Orach CG
BMC Infect Dis; 2023 Jul; 23(1):487. PubMed ID: 37479986
[TBL] [Abstract][Full Text] [Related]
7. Coverage survey and lessons learned from a pre-emptive cholera vaccination campaign in urban and rural communities affected by landslides and floods in Freetown Sierra Leone.
Gelormini M; Gripenberg M; Marke D; Murray M; Yambasu S; Koblo Kamara M; Michael Thomas C; Donald Sonne K; Sang S; Kayita J; Pezzoli L; Caleo G
Vaccine; 2023 Mar; 41(14):2397-2403. PubMed ID: 36872143
[TBL] [Abstract][Full Text] [Related]
8. Pre-emptive oral cholera vaccine (OCV) mass vaccination campaign in Cuamba District, Niassa Province, Mozambique: feasibility, vaccination coverage and delivery costs using CholTool.
Elias Chitio JJ; Baltazar CS; Langa JP; Baloi LD; Mboane RBJ; Manuel JA; Assane S; Omar A; Manso M; Capitine I; Van Rensburg C; Luiz N; Mogasale V; Marks F; Park SE; Beck NS
BMJ Open; 2022 Sep; 12(9):e053585. PubMed ID: 36547726
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of a preventive mass vaccination campaign with two doses of oral cholera vaccine during a humanitarian emergency in South Sudan.
Porta MI; Lenglet A; de Weerdt S; Crestani R; Sinke R; Frawley MJ; Van Herp M; Zachariah R
Trans R Soc Trop Med Hyg; 2014 Dec; 108(12):810-5. PubMed ID: 25311798
[TBL] [Abstract][Full Text] [Related]
10. Oral cholera vaccination coverage in an acute emergency setting in Somalia, 2017.
Lubogo M; Mohamed AM; Ali AH; Ali AH; Popal GR; Kiongo D; Bile KM; Malik M; Abubakar A
Vaccine; 2020 Feb; 38 Suppl 1():A141-A147. PubMed ID: 31980193
[TBL] [Abstract][Full Text] [Related]
11. Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model.
Kar SK; Sah B; Patnaik B; Kim YH; Kerketta AS; Shin S; Rath SB; Ali M; Mogasale V; Khuntia HK; Bhattachan A; You YA; Puri MK; Lopez AL; Maskery B; Nair GB; Clemens JD; Wierzba TF
PLoS Negl Trop Dis; 2014 Feb; 8(2):e2629. PubMed ID: 24516675
[TBL] [Abstract][Full Text] [Related]
12. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp.
Legros D; Paquet C; Perea W; Marty I; Mugisha NK; Royer H; Neira M; Ivanoff B
Bull World Health Organ; 1999; 77(10):837-42. PubMed ID: 10593032
[TBL] [Abstract][Full Text] [Related]
13. The reactive cholera vaccination campaign in urban Dhaka in 2022: experience, lessons learned and future directions.
Khan ZH; Islam MT; Amin MA; Tanvir NA; Chowdhury F; Khanam F; Bhuiyan TR; Islam A Bari T; Rahman A; Islam MN; Khan AI; Qadri F
Public Health Pract (Oxf); 2024 Jun; 7():100478. PubMed ID: 38405230
[TBL] [Abstract][Full Text] [Related]
14. Implementation research: reactive mass vaccination with single-dose oral cholera vaccine, Zambia.
Poncin M; Zulu G; Voute C; Ferreras E; Muleya CM; Malama K; Pezzoli L; Mufunda J; Robert H; Uzzeni F; Luquero FJ; Chizema E; Ciglenecki I
Bull World Health Organ; 2018 Feb; 96(2):86-93. PubMed ID: 29403111
[TBL] [Abstract][Full Text] [Related]
15. Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique.
Semá Baltazar C; Rafael F; Langa JPM; Chicumbe S; Cavailler P; Gessner BD; Pezzoli L; Barata A; Zaina D; Inguane DL; Mengel MA; Munier A
PLoS One; 2018; 13(10):e0198592. PubMed ID: 30281604
[TBL] [Abstract][Full Text] [Related]
16. The first 30 days of COVID-19 vaccination in Cameroon: achievements, challenges, and lessons learned.
Amani A; Djossaya D; Njoh AA; Fouda AAB; Ndoula S; Abba-Kabir HM; Mossus T; Nguefack-Tsague G; Kamgno J
Pan Afr Med J; 2022; 41():201. PubMed ID: 35685114
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study.
Khatib AM; Ali M; von Seidlein L; Kim DR; Hashim R; Reyburn R; Ley B; Thriemer K; Enwere G; Hutubessy R; Aguado MT; Kieny MP; Lopez AL; Wierzba TF; Ali SM; Saleh AA; Mukhopadhyay AK; Clemens J; Jiddawi MS; Deen J
Lancet Infect Dis; 2012 Nov; 12(11):837-44. PubMed ID: 22954655
[TBL] [Abstract][Full Text] [Related]
18. Highly targeted cholera vaccination campaigns in urban setting are feasible: The experience in Kalemie, Democratic Republic of Congo.
Massing LA; Aboubakar S; Blake A; Page AL; Cohuet S; Ngandwe A; Mukomena Sompwe E; Ramazani R; Allheimen M; Levaillant P; Lechevalier P; Kashimi M; de la Motte A; Calmejane A; Bouhenia M; Dabire E; Bompangue D; Kebela B; Porten K; Luquero F
PLoS Negl Trop Dis; 2018 May; 12(5):e0006369. PubMed ID: 29734337
[TBL] [Abstract][Full Text] [Related]
19. Beyond the numbers: An in-depth look at Cameroon's fifth national COVID-19 vaccination campaign through geographical and gender lenses.
Amani A; Njoh AA; Atuhebwe P; Ndoula S; Nembot R; Mbossou F; Tsague L; Adisso L; Bita Fouda AA; Gonese E; Perrault N; Habimana P; Saidu Y; Mirza I; Ntakarutimana D; Balde T; Mihigo R; Chaiban T; Gueye AS
Vaccine; 2023 Aug; 41(38):5572-5579. PubMed ID: 37524630
[TBL] [Abstract][Full Text] [Related]
20. Oral cholera vaccine coverage in hard-to-reach fishermen communities after two mass Campaigns, Malawi, 2016.
Sauvageot D; Saussier C; Gobeze A; Chipeta S; Mhango I; Kawalazira G; Mengel MA; Legros D; Cavailler P; M'bang'ombe M
Vaccine; 2017 Sep; 35(38):5194-5200. PubMed ID: 28803712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
